Stereotaxis (NYSE:STXS) announced that it submitted its Magic ablation catheter for both European and U.S. regulatory approval. The company said its FDA and CE mark submissions follow successful clinical results in an ongoing trial. Last month, Stereotaxis announced the first Magic treatments in the European trial supporting its submissions. According to a news release, the […]
Stereotaxis
10 surgical robotics companies you need to know
The surgical robotics space saw a major shakeup last year. “Robotics is hard. Robotics in healthcare is hard.” Hani Abouhalka, Johnson & Johnson’s company group chair for Robotics & Digital, said those words at our DeviceTalks West event in California in October. It pretty much sums up the situation for medtech companies large and small […]
First cases performed in Kentucky with Stereotaxis robotic magnetic navigation system
Stereotaxis (NYSE:STXS) announced today that a health provider in Kentucky performed the first procedures with its Genesis surgical robotic system. Physicians at Baptist Health Lexington successfully treated patients using the newest Stereotaxis advancement, the Genesis robotic magnetic navigation (RMN) system. Electrophysiologists at the same institution became the first to use RMN to treat patients all […]
Stereotaxis performs first surgical robot procedure with Abbott cardiac mapping tech
Stereotaxis (NYSE:STXS) today announced the first treated patients in the U.S. as part of its surgical robotics collaboration with Abbott . In May, the two companies entered a deal aimed at taking robotic electrophysiology to the next level. It sought to integrate the Abbott EnSite X EP 3D heart mapping system — with Stereotaxis’ robotic […]
Abbott, Stereotaxis ink robotic surgery partnership
Stereotaxis (NYSE:STXS) announced today that it has entered into a collaboration with Abbott (NYSE:ABT) to take robotic electrophysiology to the next level. The collaboration aims to integrate the Abbott EnSite X EP system — a 3D heart mapping system — with Stereotaxis’ robotic magnetic navigation systems. Bringing the Abbott cardiac mapping system together with Stereotaxis’ […]
Stereotaxis says system placement delays impacted revenues
Stereotaxis (NYSE:STXS) shares took a hit today on fourth-quarter results that missed the consensus sales forecast. Shares of STXS fell 6.9% to $2.42 apiece in midday trading today.MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 1.3%. The St. Louis-based endovascular surgical robot maker posted losses […]
16 surgical robotics companies you need to know
Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete. […]
Stereotaxis stock up on new orders, progress on next-gen robot
Stereotaxis (NYSE:STXS) today reported third-quarter results that missed on revenue. However, investors reacted positively to a list of positive news from the surgical robotics company. St. Louis–based Stereotaxis lost $5.3 million, or 7¢ per share, off $7.7 million in revenue for the quarter ended Sept. 30, 2022. It lost $5.0 million, or 7¢ per share, […]
Stereotaxis stock down amid cloudy outlook
Stereotaxis (NYSE: STXS) today reported second-quarter revenue that missed Wall Street projections, with the surgical robotics company unable to say how quickly revenue will pick up. Investors reacted by sending STXS shares down more than 18% to $2.10 apiece by late afternoon trading today. The St. Louis–based company lost $5.1 million, or 7¢ per share, […]
Intuitive, Acutus Medical veterans join Stereotaxis
Stereotaxis (NYSE:STXS) announced today that it appointed two new vice presidents who both have extensive industry experience. Frank Van Hyfte will join the St. Louis–based surgical robotics company as VP of Europe, the Middle East and Africa, and Tim Glynn will join as VP of market development. Van Hyfte previously spent more than 15 years […]
Stereotaxis opens new headquarters in St. Louis
Surgical robotics company Stereotaxis (NYSE: STXS) is holding a grand opening today for its 45,000 ft² headquarters facility in downtown St. Louis. The new headquarters is located in the renovated historic Globe Building in St. Louis’s growing Downtown North Urban Insight District. It’s an all-in-one facility housing research and development, advanced manufacturing, and distribution space […]